Brett Clement, Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 2001 W 68th St Ste 202, Hialeah, FL 33016 Phone: 305-364-2107 |
Dr. Christopher Wayne King, D.O. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 2001 W 68th St, Suite 202, Hialeah, FL 33016 Phone: 305-661-9404 |
Roman Bernstein, Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 2001 W 68th St, Hialeah, FL 33016 Phone: 786-596-6944 |
Eduardo G Martinez, MD Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 4051 East 8 Avenue, Suite 3, Hialeah, FL 33013 Phone: 305-835-9090 Fax: 305-694-9850 |
Tahira Hussain Chaudhry, M.D. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 2001 W 68th St, Hialeah, FL 33016 Phone: 305-661-9404 |
Dr. Alex Morizio, M.D. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 2001 W 68th St, Hialeah, FL 33016 Phone: 305-661-9404 Fax: 305-661-1510 |
Hassan Khan, Internal Medicine - Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 2001 W 68th St, Hialeah, FL 33016 Phone: 305-823-5000 Fax: 305-822-8347 |
News Archive
Sofie Biosciences, a developer of molecular imaging systems and agents, announced the launch of GENISYS4, their new benchtop small animal PET system. Introduced today at the 2011 American Association for Cancer Research Annual Meeting, this compact, preclinical multimodality PET system provides researchers with the ability to non-invasively visualize and measure the biology of disease and therapeutic response over the course of a study.
Researchers at Virginia Commonwealth University's Massey Cancer Center received a prestigious award and a $600,000 grant from the V Foundation for Cancer Research, one of the nation's leading organizations devoted exclusively to funding cancer research.
Leonor Garcia held her clipboard close to her chest and rapped on the car window with her knuckles. The driver was in one of dozens of cars lined up on a quiet stretch of road in Adelanto, California, a small city near the southwestern edge of the Mojave Desert.
Why do some of the one million people who sustain head injuries annually in United States experience a mysterious second wave of brain damage days after the initial injury - just when they appear to be recovering? Limited clinical trials using an innovative new device to monitor brain chemistry on a second-by-second basis are underway to answer that life-and-death question, according to an article in the current issue of Chemical & Engineering News (C&EN), ACS' weekly newsmagazine. Brain injury is the leading cause of death and disability worldwide.
› Verified 2 days ago